Clinical and pathological features and MYB detection in adenoid cystic carcinoma of the breast
10.13315/j.cnki.cjcep.2024.09.007
- VernacularTitle:乳腺腺样囊性癌的临床病理特征与MYB检测
- Author:
Ping CHENG
1
;
Honghai XU
;
Wengeng WANG
;
Zeyu CAI
;
Lijuan HU
;
Jun DU
Author Information
1. 安徽中医药大学第一附属医院病理科,合肥 230031
- Keywords:
breast neoplasm;
adenoid cystic carcinoma;
solid-basal cell;
MYB;
FISH;
immunohistochemistry
- From:
Chinese Journal of Clinical and Experimental Pathology
2024;40(9):930-934
- CountryChina
- Language:Chinese
-
Abstract:
Purpose To investigate the clinical and patho-logical characteristics,molecular characteristics,treatments and prognosis of adenoid cystic carcinoma(AdCC)of the breast.Methods A retrospective analysis was conducted on the clini-cal pathology of 14 breast AdCC patients,and HE,immunohis-tochemistry,FISH testing,and follow-up were performed.Re-sults All cases were female,aged 43~70 years.10 cases of classic AdCC and 4 cases of solid-basal cell AdCC(SB-AdCC)were included.The tumor was composed of epithelial,myoepi-thelial and basal-like cells arranged in sieve,tubular and solid pattern with fibrous mucinous or glassy changes in the stroma.The tumor cells of SB-AdCC were moderately to severely atypical with frequent mitosis and necrosis,accompanied by ductal carci-noma in situ(DCIS).Expression of ER(1/14),PR(1/14),HER2(0/14),CK7(14/14),p63(12/14),CK5/6(14/14),CD117(13/14),MYB(9/14)was detected;Ki67 index was 13.2%and 46.1%in classic AdCC and SB-AdCC,respec-tively.The MYB rearrangement rates in classic AdCC and SB-AdCC were 55.6%(5/9)and 25%(1/4),respectively.All patients were underwent surgical resection and/or radiotherapy and chemotherapy.During the follow-up period(2-62 months),1 SB-AdCC patient died due to lung and liver metasta-sis,while the other 10 patients survived without tumors.Con-clusion SB-AdCC is more invasive than classical AdCC with lower frequency of MYB gene rearrangement,and immunohisto-chemical detection of MYB protein has potential value in assis-ting the diagnosis of SB-AdCC.